Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 8, 2010Molecular TherapyOpen Access

Macrophage-mediated GDNF Delivery Protects Against Dopaminergic Neurodegeneration: A Therapeutic Strategy for Parkinson's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

KBKC BijuQZQing ZhouCone HealthGLGuiming LiTongji University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Biju et al. (2010) studied this question.

synapsesocial.com/papers/6a7c768a24f98b6d3fc2d680https://doi.org/10.1038/mt.2010.107
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rate of cell death in parkinsonism indicates active neuropathological process1988 · 565 citations
  2. 2MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels1994 · 125 citations
  3. 3Overexpression of Glial Cell Line-Derived Neurotrophic Factor Using a Lentiviral Vector Induces Time- and Dose-Dependent Downregulation of Tyrosine Hydroxylase in the Intact Nigrostriatal Dopamine System2004 · 153 citations
  4. 4AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY1991 · 3,559 citations
  5. 5Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator1991 · 3,063 citations